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Abstract: Hydroxyanthraquinones from plants have been used as both medicinal active ingredi-
ents and adulterants in slimming food supplements. Although sensible doses of certain natural
hydroxyanthraquinones for laxative effects are generally safe in the short term, chronic intake has
been related to tumorigenic, carcinogenic, and genotoxic effects. However, an increasing number
of researchers are reporting the antiproliferative properties of the same ingredients in cancer cells,
pointing towards a potential nutraceutical value for cancer prevention. Previous studies have evalu-
ated anthraquinones’ anti-proliferative activity against various tumour cell lines and bioavailability
in Caco-2 cells. However, there are scarce data about both their cytotoxicity in the later cell line
and long-term stability. Therefore, this study will check the purity of several ‘aged’ samples using
mutually complementary analytical techniques such as HPTLC and NMR assays as well as evaluate
the anti-proliferative activity of the purest of these samples using the Caco-2 cell line. The chromato-
graphic and spectroscopic analyses confirmed the long-term stability of those compounds, and their
cytotoxic activity resulted in chrysazin (15 µg/mL) > catenarin (27.29 µg/mL) > rhein (49.55 µg/mL)
> helminthosporin (52.91 µg/mL) > aloe-emodin (55.34 µg/mL). Our succinct review of the cytotoxi-
city of these compounds afforded two results: that this is the first clear report for catenarin being
active in colon cancer cells and that this class of compounds needs to be better studied to clearly
evaluate their benefit/risk profile in regard to both new chemo preventative nutraceuticals and
anticancer therapies.
Keywords: anthraquinones; cancer; Caco-2; NMR; cytotoxicity
1. Introduction
Anthraquinones form the basis of the medicinal and economic uses of many plants
since ancient times. Two of the most exploited aspects are their laxative [1] and colouring
effects [2]. During the last half of the 20th century, an increasing number of reports
discouraged their human use due to the genotoxic properties of some of the most commonly
found anthraquinones [3]. Recently, it has been acknowledged that these very same
toxicological properties are fundamental to unique anticancer activities mainly through
DNA damage, cycle arrest, and apoptosis [4].
As conspicuously present natural products, they form part of many dietary ingredients
in various quantities. Anthraquinone-based laxatives are safe when adequately used [5],
but both their voluntary abuse and involuntary intake as adulterants in many slimming
drinks [6] is widespread at a global scale. However, current dietary recommendations
drastically warn against daily intakes above 10–50 ppm [7]. They are still explored as
potential food colorants [8].
Amongst all cancers, Colorectal cancer (CRC) is one of the most diagnosed cancers
in the world with over 700,000 mortalities per year. Environmental and lifestyle factors
(unhealthy diets, lack of physical exercise, increase in alcohol consumption, and sleep
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disruption) have contributed to this toll. The potential implications of nutraceuticals such
as prebiotics and probiotics in the prevention and treatment of CRC has been recently
reviewed [9]. Overall, the expectations for chemoprotective nutraceuticals is high and
reported in many studies [10].
Anthraquinone derivatives are naturally occurring pigments and the largest quinone
group [11]. They are found in fungi, lichens, insects, and in the plant kingdom and occur
mainly in dicotyledon families including Hypericaceae, Polygonaceae, Rhamnaceae and
Rubiaceae [12]. Liliaceae is the only family of monocotyledons that contains this chemical
class (aloe) [13]. Approximately 90% of Anthracene occurs naturally as derivatives of
9,10 anthracenedione (anthraquinones) with different functional groups such as hydroxy,
carboxy, methyl, and hydroxymethyl groups [14]. Their biosynthetic pathways are still
somewhat unknown [15].
They are the largest group of naturally different dyes with their number in the region
of 700 compounds [16,17]. Approximately 200 of these compounds can be produced by
flowering plants, whereas the remainder can be produced by fungi and lichens, with the
most frequently reported being rhein, catenarin, and emodin [18].
Apart their ecological role, anthraquinones have a significant economic value, and
the anthraquinone market is predicted to account for $2.2 billion by 2025 [19]. Most of
them are used as pigments, but they also play a role in bioactivities such as anticancer,
anti-inflammatory, antimicrobial, laxative, antioxidant, and diuretic activities [20]. They
can be extracted from natural sources but also synthesised at an industrial scale. Essentially,
six methods exist for manufacturing anthraquinone: oxidation of naphthalene, synthetic
preparation from benzene and phthalic anhydride, oxidation of anthracene with nitric
acid, dimerization of styrene, oxidation of anthracene with chromic acid, and finally,
condensation of 1,4-naphthoquinone with butadiene [21].
Hydroxyanthraquinones are organic compound derivatives from anthraquinone
where one hydrogen atom is replaced by a hydroxyl group [22]. Therefore, they may
be included under the wider term of “polyphenolic compounds,” which are generally
endowed with health protecting properties [23]. In this regard, and apart from their clas-
sical use as laxatives, hydroxyanthraquinones have been increasingly explored for both
their pharmacology, as possessors of anticancer, [24] antioxidant, and immunosuppres-
sive properties [25], and their toxicology, as genotoxic compounds and agents in tumour
promotion [26,27]. Derivatives of Hydroxyanthraquinones have been found to exhibit
cytotoxic activity in cancer cell lines such as L1210 and have structural similarities to
some antitumour agents [28,29]. Thus, hydroxyanthraquinone derivatives can also have
mutagenic and cytotoxic activities and are therefore promising anticancer leads [24].
Although several permeability studies using Caco-2 cells are reported in the literature
for these compounds, there is an apparent lack of reports for their IC50s on this well-known
cell line. We will study the cytotoxicity and purity of selected anthraquinones, namely, aloe-
emodin, barbaloin, rhein, catenarin, chrysazin, rugulosin, and helminthosporin (Figure 1)
that were stored in a chemical library for more than 50 years by chromatographic and
spectroscopic methods. We will frame this research with a succinct review of their cyto-
toxic/antitumor properties.
1.1. Aloe-Emodin
Aloe-emodin (hereafter AE) (1,8-dihydroxy-3-(hydroxymethyl) anthracene-9,10-dione)
is a natural hydroxyanthraquinone found in various traditional medicinal plants, for
example, Aloe vera leaves and Rheum palmatum L. (Polygonaceae) [30]. It possesses laxative,
antibacterial, antiviral, and hepatoprotective effects, and many studies have reported that
AE exhibited an apoptosis effect in several cancer cell lines such as human hepatoma
cells, human tongue squamous cancer cells, gastric carcinoma cells, and cervical cancer
cells [31–33]; they have also shown that AE inhibits tumour growth via the targeting of
multiple molecules responsible for angiogenesis and cellular invasion [31].
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In in vitro studies, AE induced apoptosis in many cancer cell lines such as the human
nasopharyngeal carcinoma cells, lung squamous carcinoma cells, and lung non-small car-
cinoma cells [34–37]. Additionally, AE showed higher cytotoxic activities against human
oral squamous cell carcinoma (HSC-2), salivary gland tumour (HSG), and normal human
gingival fibroblast (HGF) cell lines [38]. Moreover, AE has a role in inducing an apoptosis
effect in human nasopharyngeal carcinoma cell lines modulated by both caspase-8 and
mitochondria [35,37]. Furthermore, it has been reported that AE has a cytotoxic effect on
neuroblastoma and Ewing’s sarcoma cell causing growth inhibition of the neuroectodermal
tumour cell line [31,39,40]. AE shows exceptional antineoplastic activity on cancer cells
lines such as colon and hepatic tumours [35–37]. This occurs via multiple molecular mech-
anisms including disruption of the cell cycle, which improves immune function, induction
apoptosis, and anti-metastasis effects [36]. Interestingly, AE possesses an antineoplastic
effect in both melanospheres and metastatic human melanoma cell lines by inducing in-
tracellular tissue transglutaminase [41–43]. Alternatively, AE did not show activity when
treated with some epithelial cancers, for instance, colon carcinoma cells, T-cell leukaemia
cells, cervix carcinoma cells, and normal fibroblasts cell lines [44]. To complicate matters
further, Mijatovic and co-workers warn of “two opposing actions of the drug: its capacity
to directly kill tumour cells, but also to protect them from NO-mediated toxicity” [45].




occurs in over 80 species of aloe [46]. Known more colloquially as “aloin”, it indicates the
crude material from which barbaloin is isolated [47]. It has been shown to have a laxative
effect in humans and animals [46]. Barbaloin did not show any cytotoxic activity in vitro in
a MTT colorimetric assay on two human colon cancer cells lines (DLD-1 and HD-29) [48].
1.3. Catenarin
Catenarin (1,4,5,7-tetrahydroxy-2-methylanthracene-9,10-dione) was first separated
and isolated as a metabolic product from the fungi Helminthsporium gramineum Raben-
horst [49]. Subsequently, catenarin (orange pigment) was found to be the main colouring
agent of Helminthsporium catenarium (current accepted name Pyrenophora tririci-repentis) [50].
In addition, catenarin can occur in leaf and wheat kernels which are infected by Pyrenophora
tririci-repentis or Aspergillus glaucus ([50,51]. It has anthraquinone derivatives, including
one methyl group and (OH) groups at positions 1, 3, 5 and 8 [50]. Yet, no studies have
reported on its cytotoxic activity.
1.4. Chrysazin
Chrysazin (1,8-dihydroxyanthraquinone) is known as danthron. It was used for the
relief of acute and chronic inflammation of the oral cavity and oropharynx, but after reports
of genotoxocity, it was discontinued [52]. It is produced in the roots of Rheum palmatum,
has laxative properties [53], and has been isolated from dried leaves and stems of Xyris
semifuscata [54]. Moreover, chrysazin has been shown to be carcinogenic to rats [3] and
significantly induces both intestinal tumours in rats and hepatocellular carcinoma in
mice [26,55]. Although chrysazin shows similar cytotoxic activity compared to AE in GLC4
and GLC4/ADR cell lines using an MTT assay [56], no significant cytotoxic activity was
reported in human solid tumour cell lines in vitro [57].
1.5. Helminthosporin
Helminthosporin (1,5,8-trihydroxy-3-methylanthraquinone) is a secondary metabolite
which can be isolated from fungi [58,59]. Moreover, it is possible to isolate it from plants
such as Cassia obtusifolia, rhizomes, and Aloe turkanensis leaves [60]. In an in vitro study,
helminthosporin exhibited anticancer properties in human extra hepatic bile duct (TFK-1)
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and liver (HuH7) cancer cell lines [61]. However, helminthosporin did not inhibit liver
(HuH7) cancer cell lines in the in vitro study [61].
1.6. Rhein
Rhein (5-dihydroxyanthraquinone-2-carboxylic acid) is a naturally occurring an-
thraquinone derivative found in rhubarb roots, such as Rheum palmatum, and various
plant species, for example, Leguminosae and Polygonaceae [62–64]. Research has shown
the biological activities of rhein, including antitumour, anti-inflammatory, anti-angiogenic,
and antibacterial activities [63,65]. It promotes in vitro apoptosis in several cancer cell
lines such as the promyelocytic leukaemia cell (HL-60), human colonic adenocarcinoma
cells, and cervical cancer Ca SKi cells [33,66]. It also induces apoptosis in nasopharyngeal
carcinoma cells and human tongue cancer cells by both caspase and mitochondrial death
pathways [33]. Similarly, it elicits in vitro cytotoxicity in primary human liver hl-7702
cells by inducing apoptosis through a mitochondria-mediated pathway [67]. Additionally,
rhein has cytotoxic activity versus HCT-116 human colon cancer cells by enhancing the
intrinsic apoptotic pathway [68]. Moreover, rhein can suppress cancer cell growth in rat
livers in vivo [33,66]. Contrarily to AE, Rhein seems to inhibit autophagy in cancer cells,
but such a prolonged effect eventually induces apoptosis [62,69].
1.7. Rugulosin
Rugulosin has a bisanthraquinone skeleton with a yellow colour [70]. It was primar-
ily isolated from fungi as diverse as Aschersonia samoensis and Penicillium rugulosum but
also identified in moulds, lichen, and various endophytic fungi [70]. It shows intriguing
biological properties, such as anti-HIV, insecticidal, and antibiotic effects, and displays hep-
atotoxicity and carcinogenic activities because of high liver accumulation [71]. In in vivo,
rugulosin displays weak toxic activity against mammalian cells, and in human hepatoma
cells (HepG2), rugulosin did not exhibit any cytotoxic activity [72].
1.8. Overall Mechanisms of Action
From the above succinct review, it seems that this class of compounds is able to
eventually trigger “programmed cell death” in cancer cells mainly via the mitochondrial-
dependent intrinsic apoptotic pathway with effects on caspases [35,37,68]. The role of ox-
idative stress in the cytotoxicity of natural hydroxyanthraquinones has been determined for
rhein, emodin, and chrysazin. They act react/compete with the single-electron-transferring
flavoenzyme ferredoxin, NADP+ reductase and NADPH–cytochrome P450 reductase,
causing oxidative stress and an increased lipid peroxidation [53]. Several studies suggest
that numerous nutraceuticals have epigenetic targets in cancers [73,74]. There is already
preliminary evidence that this is the case in regard to substituted anthraquinones (similar
to chrysazin) that can act as DNA methyltransferase 1-specific inhibitors [75]. Figure 2
summarises the mechanisms for aloe-emodin, chrysazin, and rhein; the other compounds
have not been found to be active. We prefer not to discuss molecular mechanisms following
what Dietersen and co-workers reported: that there is a high variability depending on
the structure, time schedule of treatments, and type of cell that does not allow for clear
consensus [69].
1.9. Aims
Previous studies have evaluated anthraquinones for their anti-proliferative activity
against various tumour cell lines and bioavailability in Caco-2 cells. However, there are
scarce data for their cytotoxicity in the later cell line and long-term stability. Therefore,
this study will check the purity of a number of ‘aged’ samples using mutually comple-
mentary analytical techniques such as HPTLC and NMR assays as well as evaluate the
anti-proliferative activity of the purest of these samples using the Caco-2 cell line.
Nutraceuticals 2021, 1 18
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2. Material and Methods
2.1. Compounds and Reagents
The compounds were sourced from the chemical library of the former Department of
Pharmacognosy (The School of Pharmacy, University of London). These compounds were
isolated by the late Prof Fairbairn as described elsewhere [1,76–79].
2.2. Thin Layer Chromatography
Development of mobile phases prior to their use in high-performance thin-layer
chromatography was achieved through classic thin-layer chromatography using silica gel
TLC plates 60 F 254 (Merck, Darmstadt, Germany) and solvent of HPLC grade (Sigma
Aldrich, Dar stadt, Germany) in glass chromatographic tanks saturated with the mobile
phase by means of filter paper (Whatman, Darmstadt, Germany).
2.3. High-Performance Thin-Layer Chromatography
To ensure that i purities after long storage were within acceptable limits, we devel-
oped and ran two dif erent conditions f hig -performance thin-layer chromatography
analyses. The equipment consisted of a Linomat 5 (CAMAG, Hungerford, UK) coupled
with a 100 µL syringe (CAMAG, Hungerford, UK) and compressed air with 60–90 psi., an
Automatic Developing Chamber ADC 2 (CAMAG, Hungerford, UK), and a TLC Visualizer
(CAMAG, Hungerford, UK). The compounds were dissolved in 2 µL of 75% methanol,
and an extract of each sample was loaded on HPTLC plates silica gel 60 F 254 (Merck,
Hungerford, UK). The HPTLC was started after the developing solvent system was satu-
rated for 20 min and pre-conditioned for 5 min. The condition of the tank was held at a
humidity of 33% and a temperature of 23 ◦C. The process stopped once the developing
solvent reached the plate at an 80 mm migration distance. After 5 min plate drying, the
plates were visualized under white light at 254 and 366 nm wavelengths. VisionCATS, the
HPTLC workflow and analytical software, was used in plate analysis and graphic editing.
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2.4. Nuclear Magnetic Resonance
Compounds were dissolved in 600 µL of deuterated solvent in an NMR tube (VWR
international Ltd., Lutterworth, UK) and submitted to a Bruker Advance 500 MHz spec-
trometer (Bruker, Coventry, UK). Standard protocols for 1D (1H, 13C, Dept 135, and Dept
90) and 2D (COSY, HMQC, and HMBC) experiments were applied. Spectra were processed
using Top Spin software (Bruker, Coventry, UK).
2.5. Anti-Proliferative Activity
Anti-proliferative activity was assessed via an SRB assay. This assay determines
the ability of the extract to inhibit cellular growth by measuring the cell density, thereby
estimating cell number. This assay was performed according to a previously described
method [80]. Caco-2 cells were seeded at a density of 10,000 cells/well in a 96-well plate
(Thermo Scientific, Waltham, MA, USA) and left overnight to attach at 37 ◦C. Afterwards,
cells were treated with a serial dilution of the plant extracts. Upon the completion of the
incubation period, the cells were fixed with trichloroacetic acid solution for one hour at
4 ◦C. After washing with water, cellular protein was stained with SRB solution and left at
room temperature for one hour; this was followed by washing the plate four times with
1% acetic acid and flicking to remove unbound dye. Then, a Tris base buffer solution was
added to each well, and the absorbance was measured at 510 nm (M200 Infinite, Tecan,
Männedorf, Switzerland). Cell growth was calculated using the following equation:
%Cell growth =
Absorbance (sample)− Absorbance (blank)
Absorbance (vehicle control)− Absorbance (blank) × 100 (1)
Each concentration of samples (100 µg/mL, 50 µg/mL, 25 µg/mL, 12.5 µg/mL,
6.25 µg/mL, 3.125 µg/mL) was evaluated in triplicate. Each experiment was performed
twice. The concentration affecting the “Growth inhibition 50%” (abbreviated GI50) was
calculated using a Quest Graph IC50 Calculator [81].
3. Results
3.1. Development of High-Performance Thin-Layer Chromatography Systems for the
Determination of the Purity of Hydroxyantharquimones
Many mobile phase systems have been trialled in classic TLC according to the literature
reviews in order to find a suitable system; these include ethyl acetate-methanol-water
(10:2:1), petrol ether-ethyl acetate-formic acid (75:25:1), petrol ether-ethyl acetate-formic
acid (75:25:1), and toluene-ethyl acetate-ethanol-formic acid (10:8:1:2) [82–88]. The results
of all these systems showed unsuccessful separation and similar Rf values, and all the
bands migrated and appeared at the top of the plate with polar systems. In addition, once
the polarity of the mobile phase decreased, some compounds such as rugulosin, rhein,
and barbaloin did not migrate and showed no spots. After testing over 30 different TLC
conditions previously reported, we opted for developing two new conditions due to their
differences in polarity. Two different mobile phases were finally chosen: (1) ethyl acetate: 2-
propanol: formic acid (84:16:1 v/v/v) and (2) hexane fraction from petroleum: chloroform:
formic acid (80:2:1 v/v/v). These are the best for separation of rugulosin/rhein/barbaloin
and aloe-emodin/catenarin/chrysazin/helminthosporin, respectively. Table 1 and Figure 3
show the results and Rf values of the major bands.
The transfer of the TLC method into HPTLC experiments showed that catenarin and
helminthosporin were as seen in TLC (data not shown), but, interestingly, chrysazin and
aloe-emodin exhibited one more spot (Figure 3). In the second experiment, barbaloin
showed at least four spots, which confirms that it contained some more impurities besides
the aglycone. Furthermore, long and large bands were displayed by rugulosin, which
may be due to some contaminations. Finally, compared to the TLC plate, rhein displayed
approximately the same result with only one spot, suggesting an absence of contamination.
This is due to the higher power or separation of the HPTLC over TLC.
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Table 1. Rf values of the selected anthraquinones in two different mobile phases.
Compounds System 1 System 2
Rugulosin 0.68, 0.74 and 0.79 -
Rhein 0.38 -
Barbaloin 0.28 and 0.79 -
Aloe-emodin - 0.10
Catenarin - 0.35 and 0.44
Chrysazin - 0.14
Helminthosporin - 0.22 and 0.30
(1) Ethyl acetate: 2-propanol: formic acid (84:16:1 v/v/v). (2) Hexane fraction from petroleum: chloroform: formic
acid (80:2:1 v/v/v).
Nutraceuticals 2021, 1,  8 
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Figure 3. HPTLC plates showing aged (a) rugulosin/rhein/ rbaloin luted using System 1 and
(b) aloe-emodin/catenarin/chrysazin/helminthosporin eluted using System 2.
3.2. NMR Studies
Our experimental data were compared to the data provided by both an in-silico pre-
diction made by the computer application Chemdraw (Perkin Elmer, Bucks, UK) and those
reported in the literature to ascertain potential differences between authors, equipment,
and the validity of predictive algorithms. In addition, they enabled the observation of the
relative purity of the compounds.
3.2.1. NMR Spectroscopic Characteristics of Aged Aloe-Emodin
A comparison of the results of the experiment and literature review published by
Sanchez et al., (2011) for 1H and 13C chemical shifts showed approximately the same
chemical shifts (see Table 2). On the other hand, the ChemDraw prediction displayed
a slightly different chemical shift for 13C, which might be due to the low of frequency
at 300 MHz. The proton’s chemical shift showed that this compound has six protons at
positions 2, 4, 5, 12, 13, and 14 and the Heteronuclear Multiple Quantum Correlation
(HMQC) between protons and carbons had been determined (see Table 2). Moreover,
the 13C Chemical Shift illustrated that aloe-emodin has nine quaternary carbons and two
of them are carbonyl groups at 8 and 11 position (191.62 and 181.46 MHz, respectively)
(see Table 2). Additionally, both carbon Dept 135 and Dept 90 exhibited a clear spectrum
for CH and CH2. Therefore, it can be deduced that this compound is pure with some
minor contaminations.
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1H Peak Shape 13C 1H 13C 1H 13C
1 – – 161.62 – 162.1 – 162.3
2 7.29 S 120.64 7.11 120.6 7.29 121.4
3 – – 153.9 – 153.2 – 154.4
4 4.62 S 62.12 4.61 65.0 4.62 62.7
5 7.69 S 117.01 7.34 118.3 7.69 117.8
6 – – 133.09 – 133.6 – 133.9
7 – – 114.48 – 115.2 – 115.2
8 – – 191.62 – 188.0 – 192.4
9 – – 115.91 – 116.3 – 116.7
10 – – 133.31 – 133.1 – 134.1
11 – – 181.46 – 182.1 – 182.2
12 7.71 D 119.34 7.74 119.4 7.72 120.0
13 7.80 T 137.74 7.65 136.2 7.80 138.0
14 7.38 D 124.38 7.06 124.1 7.38 125.1
15 – – 161.33 – 161.9 – 162.0
3.2.2. NMR Spectroscopic Characteristics of Aged Barbaloin
Both the 1H and 13C Chemical Shift results exhibited extra proton and carbon peaks
(data not shown) in accordance with the results of TLC and HPTLC plates showing the
presence of impurities.
3.2.3. NMR Spectroscopic Characteristics of Aged Catenarin
The results of the experiment and the ChemDraw prediction demonstrated similar
1H and 13C Chemical Shift values (See Table 3). However, no research has established
catenarin’s 13C Chemical Shift. In addition, the results of the 1H Chemical Shift were in
agreement with those published by Kalidhar [90]. This compound has four protons and
eleven quaternary carbons, two of which are carbonyl groups at position 7 and 10 (186.0
and 187.71 MHz, respectively). The proton and carbon correlation (HMQC) for the two
experiments showed similar chemical shifts; small variations were due to the different
frequencies that were used (300 and 500 MHz). Moreover, both carbon Dept 135 and
Dept 90 exhibited a clear spectrum for CH and CH3 (Supplementary Materials). Finally,
as TLC and HPTLC plates for this compound displayed more than one spot and both
the 1H and 13C spectrum showed some extra signals, this compound has some minor
contamination only.








1H Peak Shape 13C 1H 13C 1H 13C
1 – – 164.43 – 163.3 NO Data
2 6.58 ds 108.19 6.48 107.0 6.66
3 – – 165.51 – 164.5
4 – – 108.97 – 108.9
5 – – 134.70 – 136.4
6 7.13 ds 108.30 6.75 108.3 7.13
7 – – 186.0 – 186.4
8 – – 110.07 – 111.7
9 – – 111.43 – 111.7
10 – – 187.71 – 188.0
11 – – 156.04 – 157.4
12 7.24 s 129.09 6.82 129.4 7.32









1H Peak Shape 13C 1H 13C 1H 13C
13 – – 139.75 – 140.9
14 – – 156.74 – 158.0
15 2.25 S 15.87 2.15 15.4 2.35
3.2.4. NMR Spectroscopic Characteristics of Aged Chrysazin
Both the study published by Pullella et al. [91] and the experimental results demon-
strated roughly the same 1H and 13C Chemical Shift values as those from the ChemDraw
prediction, which showed a slightly different Chemical Shift (see Table 4). As this com-
pound is symmetrical, both 1H and 13C illustrated clear and long signals. This compound
has six protons, and eight quaternary carbons appear as long signal. Moreover, among of
the quaternary carbons, two of them are carbonyl carbons at position 7 and 10 (181.38 and
192.01 MHz) and two attach to hydroxyl groups at position 4 and 11 (161.30 MHz). Addi-
tionally, both carbon Dept 135 and Dept 90 exhibited three large signals as this compound
is symmetrical (see Supplementary Materials). Therefore, as per TLC, HPTLC and NMR
results, it can be deduced that this compound is pure (See Table 4).








1H Peak Shape 13C 1H 13C 1H 13C
1 7.71 DD 119.29 7.74 119.4 7.70 120.2
2 7.81 DD 137.44 7.65 136.2 7.80 138.0
3 7.39 DD 124.39 7.06 124.1 7.37 125.1
4 – – 161.30 – 161.9 – 163.0
5 – – 115.94 – 116.3 – 116.7
6 – – 133.28 – 133.1 – 134.4
7 – – 181.38 – 182.1 – 182.0
8 – – 133.28 – 133.1 – 134.4
9 – – 115.94 – 116.3 – 116.7
10 – – 192.01 – 188.0 – 193.4
11 – – 161.30 – 161.9 – 163.0
12 7.39 DD 124.39 7.06 124.1 7.37 125.1
13 7.81 DD 137.44 7.65 136.2 7.80 138.0
14 7.71 DD 119.29 7.74 119.4 7.70 120.2
3.2.5. NMR Spectroscopic Characteristics of Aged Helminthosporin
For helminthosporin, all three experiments illustrated nearly the same 13C Chemical
Shift values, and the ChemDraw prediction showed slightly different results for 1H Chemi-
cal Shift compared to the rest (Table 5). This compound has five protons at position 2, 3,
11, 13, and 15 and ten quaternary carbons, two of which are carbonyl groups at position 7
and 10 (189.94 and 186.36 MHz). The 1H Chemical Shift values demonstrated some small
peaks, which implies that it contained minor contaminations (see Supplementary Materi-
als). Moreover, the Dept 135 spectrum indicated that there are four protons attached to the
aromatic rings at position 2, 3, 11, and 14 and a methyl group at position 13 (2.46 MHz). As
per TLC, HPTLC, and NMR results, it can be deduced that this compound contained some
minor compounds or contaminations.
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1H Peak Shape 13C 1H 13C 1H 13C
1 – – 157.06 – 157.3 – 158.2
2 7.44 S 129.43 7.37 129.5 7.44 129.5
3 7.44 S 129.69 7.37 129.5 7.44 129.6
4 – – 156.39 – 157.3 – 157.6
5 – – 112.71 – 114.7 – 112.8
6 – – 112.55 – 114.7 – 112.5
7 – – 189.94 – 188.0 – 190.6
8 – – 113.84 – 113.3 – 114.0
9 – – 132.88 - 133.3 – 133.2
10 – – 186.36 – 185.5 – 186.6
11 7.64 S 120.29 7.22 120.2 7.65 120.8
12 – – 149.14 – 147.6 – 149.1
13 2.46 S 21.63 2.36 21.6 2.45 22.3
14 7.26 S 124.3 6.66 122.7 7.26 124.6
15 – – 161.68 – 161.8 – 162.8
3.2.6. NMR Study of Aged Rhein
All three experiments displayed similar 1H and 13C Chemical Shift values with some
variations (see Table 6). The 1H Chemical Shift revealed some impurities and extra signals,
which indicates that it might have contained some minor compounds. It has five protons
and ten quaternary carbons; two of them are carbonyl groups at position 8 and 11 (181.7
and 187.38 MHz). Furthermore, it also has two hydroxyl groups attached to carbon at
position 4 and 12 (161.10 and 158.31 MHz) and one carboxylic group at position 1 (165.55).
Lastly, even though Dept 135 and Dept 90 displayed clear signals, it also showed small
peaks that could not be integrated, which suggested some minor contaminations (see
Supplementary Materials).








1H Peak Shape 13C 1H 13C 1H 13C
1 – – 165.55 – 169.3 – 165.52
2 – – 128.01 – 135.0 – 138.20
3 7.76 DS 123.93 7.81 124.5 7.77 124.21
4 – – 161.10 – 160.1 – 161.51
5 – – 119.6 – 121.5 – 118.48
6 – – 132.95 – 131.5 – 133.61
7 8.13 DS 118.03 7.56 120.6 8.14 119.05
8 – – 181.7 – 182.1 – 181.25
9 – – 134.8 – 133.1 – 133.41
10 – – 120.63 – 116.3 – 116.33
11 – – 187.38 – 188.0 – 191.49
12 – – 158.31 – 161.9 – 161.27
13 7.74 DD 122.42 7.06 124.1 7.41 124.64
14 7.91 – 136.26 7.65 136.2 7.84 137.63
15 7.90 – 120.57 7.74 119.4 7.75 119.48
3.2.7. NMR Spectroscopic Characteristics of Aged Rugulosin
This compound could not be interpreted due to rugulosin’s many extra protons and
carbons (data not shown). Rugulosin is a symmetrical compound and has 18 protons and
its 1H Chemical Shift values demonstrated an unclear spectrum. In addition, some peaks
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were difficult to integrate, and the 13C Chemical Shift values showed 30 carbons because
this compound is symmetrical. As already seen in TLC and HPTLC plates, rugulosin
displayed more than three spots. Therefore, it can be concluded that this compound had
major contamination.
3.3. Anti-Proliferative Activity
Our results (Table 7) point towards a similar mild cytotoxicity of the selected hy-
droxyanthraquinones that are one or two orders of magnitude higher than the reference
anticancer drug paclitaxel.
Table 7. Antiproliferative activity of the anthraquinones in Caco-2 (human colorectal adenocarci-
noma) in the SRB assay (48 h).
Compound GI50 (µg/mL) GI50 (µM) (CI 95%)
Aloe-emodin 55.34 204.8 (174.1–237.6)
Catenarin 27.29 95.3 (81.0–110.5)
Chrysazin 15.26 63.5 (54.0–73.7)
Helminthosporin 52.91 195.8 (166.4–227.1)
Rhein 49.55 174.3 (148.2–202.2)
Paclitaxel 1.78 2.1 (1.8–2.4)
4. Discussion
4.1. Purity and Identity of the Compounds as a Proxy to Determine Their Long Term Stability
The samples used in this project were stored for more than 50 years at room tem-
perature, and our hypothesis was that this may be a means to understand the long-term
stability of such compounds. To ascertain both their purity and identity, HPTLC and NMR
were applied, respectively.
With regards to the NMR method, each compound has been analysed by means of
different experiments to check their purity, namely, 1H, 13C, Dept 135, Dept 90, Cosy,
HMQC, and HMBC experiments (see Supplementary Materials for all spectra). All the
compounds were consistent with the literature and prediction data except the rugulosin
and barbaloin aged samples. These could not be interpreted due to the 13C and the many
extra protons and carbons that made it difficult to integrate. As already seen in TLC and
HPTLC plates, rugulosin displayed more than three spots. Therefore, it can be concluded
that these compounds had major contamination and/or impurities.
Overall, the outcomes of HPTLC and NMR analyses demonstrated that five out of
the seven compounds isolated by the late Prof. Fairbairns were intact and pure after
decades of storage at room temperature, with only some minor contaminations. Only
barbaloin and rugulosin presented major contaminations and were excluded from SRB
assay, although their purity may still be at the level of reagent grade. Thus, the stability
of these compounds seems to be higher in the case of aglycones and lower in the case of
glycosides and/or dimers. Therefore, aglycones can be stored for long periods of time just
at room temperature and away from light and humidity.
4.2. General Toxicity of Selected Anthraquinones, Their Activity on Caco-2 Cells and Cytotoxicity
in Other Cancer Cells as a Proxy to Determine Their Nutraceutical Interest
Both catenarin and chrysazin exhibited the best anti-proliferative activity towards the
Caco-2 cell line among the tested hydroxyanthraquinones. However, this activity remains
one factor of magnitude away from potent cytotoxic drugs of reference, such as paclitaxel.
It is difficult to find any obvious structure–activity correlation in terms of functionality.
This is not the first time researchers have failed to rationalise the pleiotropic activities
of anthraquinones. Deitersen and co-workers described the cytotoxic effects of all an-
thraquinones as seemingly “dependent on various factors such as cellular model system,
parallel stimulation of pathways, concentration of compounds, administration form and
incubation times”. These results show each compound acting differently depending on the
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cell types. However, it is clear that the three rings, two para-keto groups, and hydroxylation
in positions C1, C3 and C8 are essential for the bioactivity of such compounds and their
pleiotropic effects upon multiple pathways [69].
In our case, the presence of some impurities may further complicate the discussion.
However, we can discuss how Caco-2 is being used as a proxy model for the toxicology
of the intestinal epithelium cells [93]. In this context, our results match some pre- and
clinical observations of a general lack of clear toxicity for the consumption of sources
of such anthraquinones despite being sold during many years as laxative [54]; these
results also match contradictory reports of carcinogenesis (experimental, not clinical) for
chrysazin [55,94]. This compound was used in the past as a laxative to relieve constipation
in refractory patients under the name “dantron” (in UK) or “danthron” (USA and elsewhere)
until animal toxicological studies reported evidence that oral exposure to this substance
caused liver cancer (hepatocellular carcinoma) in male mice and benign and malignant
intestinal-tract tumours (adenoma and adenocarcinoma of the colon and adenoma of the
cecum) in male rats [95]. According to Van Gorkom et al. [56], chrysazin exhibits cytotoxic
activity towards drug resistant lung small cell (GLC4 and GLC4/ADR) carcinoma in the
MTT assay. However, no other studies have discussed its anti-proliferative activity.
Regarding catenarin, we have shown it to be mildly active against Caco-2 cell line.
As far as we know, there is no clear reports on either its cytotoxicity or anti-proliferative
activity. Previous reports point towards no activity (GI50 > 100 µM) in Vero, Wish, Calu1,
Raji, and HeLa tumour cells [96]. Therefore, this might be the first time that this compound
is shown as cytotoxic.
The chemo preventative role of anthraquinones as nutraceuticals or their anticancer
potential seem to be hampered by several reports of in vitro, in vivo carcinogenesis. They
do not seem to be translated into a high incidence of cancer in humans, and the only
available report is from a patient with very high chronic consumption [97]. The toxicity
of anthraquinone-containing plant preparations is confounded by the co-occurrence of
other toxins, chiefly oxalic acid in rhubarb species [98]. Two recent reports point out the
potentially negative effects of anthraquinones on the immune system. On the one hand,
emodin had an antiproliferative and apoptotic effect in human T cells characterised by acute
stress of the endoplasmic reticulum, high intracellular free Ca2+, alteration to mitochondrial
membrane potential, leaking of cytochrome C to the cytosol level, and increased caspase-3,
-4, and -9 activities resulting in increased levels of radicals and lipoperoxidative damage.
The authors propose that concomitant administration of N-acetylcysteine—a popular
nutraceutical—protects from these effects [99]. On the other hand, it also caused DNA
damage to human peripheral blood lymphocytes, which resulted in oxidative stress [100].
There is, however, a case to harness the cytotoxicity of the hydroxyanthraquinones by
creating derivatives with a more positive benefit/risk balance. This approach may afford
new molecules that are safe for regular consumption in the context of a varied diet and
healthy lifestyle to support gastrointestinal health and may eventually prevent malignan-
cies as “off label nutraceutical”. The fact that many fungi (endophytes, in particular) are
able to synthesise these molecules, perhaps due to horizontal plant–fungus transfer [101],
may allow for scaling up of the production.
5. Conclusions
The outcomes of HPTLC and NMR analyses demonstrated a remarkable stability in
the case of aglycones and a somewhat lower stability in the case of their glycosides and/or
dimers. In the later group, barbaloin and rugulosin presented major impurities and were
excluded from the proliferation assay, although their purity may be still at the level of
reagent grade. Thus, the stability of aglycones of monohydroxyanthraquinones seems to
be very high and not a concern when stored at room temperature and away from light
and humidity. The anti-proliferative activity of these compounds in the Caco-2 cell line
after 48 h treatment unveiled better anti-proliferative activity for catenarin and chrysazin
(GI50 < 30 µg/mL), whereas rhein, aloe-emodin, and helminthosporin are endowed with
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lower anti-proliferative activity (30 µg/mL < GI50 < 100 µg/mL). Our succinct review of
the cytotoxicity of these compounds afforded two results: that this is the first clear report
for catenarin being active in colon cancer cells and that this class of compounds needs to
be better studied to clearly evaluate their benefit/risk profile towards both new chemo
preventative nutraceuticals and anticancer therapies.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/nutraceuticals1010004/s1; NMR spectra are presented as Supplementary Materials.
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